[DOI] [PubMed] [Google Scholar] 94.Dunn G.P., Spiliopoulos K., Plotkin S.R., Hornicek F.J., Harmon D.C., Delaney T.F., Williams Z
Recent clinical studies on these drugs seem to offer new hope for some conditions, such as age related macular degeneration and uveitis, they highlight, but with potential risks of severe, though rare, ocular complications, such as ION, for others. 10/03/2026 Notes for editors Short report: Ischemic optic neuropathy with semaglutide: global observational analysis of sex- and formulation- specific risk Doi:10.1136/bjo-2025-328483 Commentary: Effects of anti-obesity medications in the retina: a gathering storm or sunshine ahead
Tirzepatide is approved for moderate to severe obstructive sleep apnea in adults with obesity
Its almost like I didnt realize how loud or constant it was until it was gone